Additionally, we show that PRL exposure sensitizes CRC cells to TRAIL-induced apoptosis, supporting the potential of TRAIL-based therapies, particularly in liposomal form, as a pregnancy-compatible treatment approach. This evidence concerns the gene PRL and colorectal carcinoma.